Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04076579
Title Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Indications

liposarcoma

sarcoma

leiomyosarcoma

Therapies

Olaparib + Trabectedin

Age Groups: adult senior child


No variant requirements are available.